Compare ZTS & RELX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZTS | RELX |
|---|---|---|
| Founded | 1952 | 1903 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.8B | 53.2B |
| IPO Year | 2012 | N/A |
| Metric | ZTS | RELX |
|---|---|---|
| Price | $126.80 | $34.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 2 |
| Target Price | ★ $156.20 | N/A |
| AVG Volume (30 Days) | 3.9M | ★ 5.0M |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | 1.64% | ★ 2.50% |
| EPS Growth | ★ 10.05 | N/A |
| EPS | ★ 6.02 | N/A |
| Revenue | ★ $9,467,000,000.00 | N/A |
| Revenue This Year | $5.79 | $9.40 |
| Revenue Next Year | $5.16 | $6.22 |
| P/E Ratio | $21.45 | ★ $20.27 |
| Revenue Growth | ★ 2.28 | N/A |
| 52 Week Low | $115.25 | $27.57 |
| 52 Week High | $177.00 | $56.33 |
| Indicator | ZTS | RELX |
|---|---|---|
| Relative Strength Index (RSI) | 49.18 | 56.56 |
| Support Level | $118.13 | $27.57 |
| Resistance Level | $130.08 | $41.06 |
| Average True Range (ATR) | 4.15 | 0.79 |
| MACD | 0.02 | 0.92 |
| Stochastic Oscillator | 58.01 | 96.66 |
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
RELX is a global provider of information-based analytics and decision tools for professional and business customers in various industries. The company serves sectors such as science and medical research, risk management, and legal. In addition, RELX organizes large-scale digital and face-to-face events such as industry trade shows. Around 60% of revenue is generated in North America and about 20% in Europe.